Joyce Yestrepsky
Optometrist · Sterling Heights, MINPI 1902854326
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,050 of the $2,746 with a category attached, or 74.6%. Johnson & Johnson Vision Care, Inc. accounts for 81.7% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2022 at $2,093 and has fallen 88.9% since, to $232 in 2025.
Across 39 payments — averaging $70.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Vision Care, Inc.$2K
- Alcon$89
- Coopervision Inc.$78
- Bausch & Lomb Americas Inc.$72
- Bausch & Lomb, A Division Of Bausch Health US, LLC$71
- Tarsus Pharmaceuticals, Inc.$63
- plus $129 from 5 others
What the payments were for
- Consulting fees$2,05075%
- Food & beverage$69625%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Vision Care, Inc. | 13 | $2,245 |
| Alcon | 5 | $89 |
| Coopervision Inc. | 3 | $78 |
| Bausch & Lomb Americas Inc. | 4 | $72 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 4 | $71 |
| Tarsus Pharmaceuticals, Inc. | 3 | $63 |
| Sun Pharmaceutical Industries Inc. | 2 | $33 |
| Visioneering Technologies, Inc. | 2 | $32 |
| Harrow Eye, LLC | 1 | $25 |
| Amgen | 1 | $20 |
| Biotissue Holdings Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Acuvue$2,025
How this compares
$2,746 in reported general payments places this provider in the 85th percentile of 1,523 optometrist providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 12 | $157 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Sterling Heights
- Jamie KuzniarBloomfield$473K
- Monica JohnsonbaughGrosse Pointe$393K
- Nicholas BrunsFlint$238K
- Jay CrankGrand Rapids$209K
- Jeffrey VaranelliWarren$204K
- Thomas RothAnn Arbor$98K
- Frances Poma NowinskiBloomfield Twp$91K
- Michael LipsonWalled Lake$77K
- Stephanie RamdassBig Rapids$59K
- Robert FarrellMount Clemens$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.